Padmasri Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
as on 17-12-2024
- Revenue -8.07%
(FY 2022)
- Profit 101.14%
(FY 2022)
- Ebitda -54.41%
(FY 2022)
- Net Worth 0.79%
(FY 2022)
- Total Assets -0.29%
(FY 2022)
About Padmasri Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M.
Srinivas Jegannathan and Suresh Nair serve as directors at the Company.
- CIN/LLPIN
U74120MH2014PTC252217
- Company No.
252217
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Padmasri Lifesciences Private Limited offer?
Padmasri Lifesciences Private Limited offers a wide range of products and services, including Massage Equipments & Spa Devices, Foot and Calf Massager, Common Disease Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Padmasri Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivas Jegannathan  | Director | 18-Jan-2014 | Current |
| Suresh Nair | Director | 28-Oct-2015 | Current |
Financial Performance of Padmasri Lifesciences.
Padmasri Lifesciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.07% decrease. The company also saw a substantial improvement in profitability, with a 101.14% increase in profit. The company's net worth moved up by a moderate rise of 0.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Padmasri Lifesciences?
In 2017, Padmasri Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 15 Oct 2016 | ₹3.00 M | Open |
How Many Employees Work at Padmasri Lifesciences?
Unlock and access historical data on people associated with Padmasri Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Padmasri Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Padmasri Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
